NCT04343755: A reported trial by Hackensack Meridian Health
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04343755 |
|---|---|
| Title | Phase IIa Study Exploring the Safety and Efficacy of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Hospitalized Subjects With COVID-19 Infection |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 9, 2020 |
| Completion date | April 26, 2023 |
| Required reporting date | April 25, 2024, midnight |
| Actual reporting date | June 22, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |